Gene · 3385
Papers1,776
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,776
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-155-regulated mTOR and Toll-like receptor 5 in gastric diffuse large B-cell lymphoma. | Cancer Med | 2022 | 34913612 | PubTator, text mining | PubMed |
| Engineered extracellular vesicles for concurrent Anti-PDL1 immunotherapy and chemotherapy. | Bioact Mater | 2022 | 34820569 | PubTator, text mining | PubMed |
| Pediatric ECMO: unfavorable outcomes are associated with inflammation and endothelial activation. | Pediatr Res | 2022 | 34732815 | PubTator, text mining | PubMed |
| Unboxing the molecular modalities of mutagens in cancer. | Environ Sci Pollut Res Int | 2022 | 34611806 | PubTator, text mining | PubMed |
| Antimicrobial protein REG3A and signaling networks are predictive of stroke outcomes. | J Neurochem | 2022 | 34558059 | PubTator, text mining | PubMed |
| Primary breast cancer biomarkers based on glycosylation and extracellular vesicles detected from human serum. | Cancer Rep (Hoboken) | 2022 | 34423573 | PubTator, text mining | PubMed |
| Diversity of transcriptomic microglial phenotypes in aging and Alzheimer's disease. | Alzheimers Dement | 2022 | 34223696 | PubTator, text mining | PubMed |
| One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-CoV-2. | Allergy | 2022 | 34180546 | PubTator, text mining | PubMed |
| Continued dysregulation of the B cell lineage promotes multiple sclerosis activity despite disease modifying therapies. | F1000Res | 2021 | 37655229 | PubTator, text mining | PubMed |
| Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16- Monocytes From COVID-19 Patients. | Front Immunol | 2021 | 35095880 | PubTator, text mining | PubMed |
| Where the Action Is-Leukocyte Recruitment in Atherosclerosis. | Front Cardiovasc Med | 2021 | 35087886 | PubTator, text mining | PubMed |
| Dental Mesenchymal Stem Cell Secretome: An Intriguing Approach for Neuroprotection and Neuroregeneration. | Int J Mol Sci | 2021 | 35008878 | PubTator, text mining | PubMed |
| Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy. | Epigenomes | 2021 | 34968251 | PubTator, text mining | PubMed |
| Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19. | Front Immunol | 2021 | 34966385 | PubTator, text mining | PubMed |
| Survival Advantage Following TAG-72 Antigen-Directed Cancer Surgery in Patients With Colorectal Carcinoma: Proposed Mechanisms of Action. | Front Oncol | 2021 | 34950576 | PubTator, text mining | PubMed |
| Artificial Neural Networks Predicted the Overall Survival and Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Pancancer Immune-Oncology Panel. | Cancers (Basel) | 2021 | 34945004 | PubTator, text mining | PubMed |
| Lonomia obliqua Envenoming and Innovative Research. | Toxins (Basel) | 2021 | 34941670 | PubTator, text mining | PubMed |
| SARS-CoV-2 uses metabotropic glutamate receptor subtype 2 as an internalization factor to infect cells. | Cell Discov | 2021 | 34903715 | PubTator, text mining | PubMed |
| Multi-omics analysis of an immune-based prognostic predictor in non-small cell lung cancer. | BMC Cancer | 2021 | 34893051 | PubTator, text mining | PubMed |
| Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis. | Front Immunol | 2021 | 34887867 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3385/papers?page=15